Pricing Log in Create free account

Silo Pharma, Inc. (SILO) vs Trevena, Inc. (TRVN)

Silo Pharma, Inc. and Trevena, Inc. are both Biotechnology companies. Silo Pharma, Inc. and Trevena, Inc. are of similar size ($1.9M and $1.8M). Silo Pharma, Inc. grew revenue faster over the last twelve months: 0.00% against −83.0%. Silo Pharma, Inc. has the higher net margin (0.00% vs −6,233.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Silo Pharma, Inc. leads on 9 and Trevena, Inc. on 6.

Valuation

Metric SILO TRVN Biotechnology median
P/E n/m n/m 8.50
P/S 18.00 n/m 9.71
P/B 0.27 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.90 n/m 0.64
EV/Sales (54.56) 35.04 9.21
Earnings yield (369.34%) 0.00% (33.15%)
Free cash flow yield (302.55%) 0.00% (25.50%)

Profitability

Metric SILO TRVN Biotechnology median
Gross margin 11.81% (190.29%) 65.16%
Operating margin 0.00% (5,879.85%) 0.00%
Net margin 0.00% (6,233.70%) 0.00%
Free cash flow margin 0.00% (4,961.72%) 0.00%
Return on equity (91.23%) 344.49% (56.36%)
Return on assets (70.96%) (105.83%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric SILO TRVN Biotechnology median
Revenue growth (TTM) 0.00% (82.97%) 6.02%
EPS growth (last fiscal year) 57.98% 58.37% 30.26%
Revenue growth, 5-year CAGR 12.17% (11.43%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SILO TRVN Biotechnology median
Debt to equity 0.00 (1.41) 0.00
Current ratio 5.36 2.42 4.72
Net debt to EBITDA 1.61 0.06 0.96

Dividend

Metric SILO TRVN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric SILO TRVN Biotechnology median
Market cap 1.91m 1.81m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack